SEC Form 4 · accession 0001437749-15-004198
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald Lane Midyett
Officer — Executive Vice President
Period of report
Mar 3, 2015
Accepted (ET)
Mar 5, 2015 · 4:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 3, 2015 | M | 36,821 | $6.19 | A | 92,693 | D | |
| Common StockF3 | Mar 3, 2015 | M | 16,164 | $14.10 | D | 76,529 | D | |
| Common Stock | Mar 3, 2015 | M | 30,179 | $6.19 | A | 106,708 | D | |
| Common StockF1 | Mar 3, 2015 | M | 19,610 | $14.10 | D | 87,098 | D | |
| Common Stock | Mar 3, 2015 | M | 52,500 | $6.22 | A | 139,598 | D | |
| Common StockF2 | Mar 3, 2015 | M | 34,410 | $14.10 | D | 105,188 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (Right to Buy) | $6.19 | Mar 3, 2015 | X | 36,821 | A | May 28, 2013 | May 28, 2017 | Common Stock | 36,821 | 0 | D |
| NonQualified Stock Option (Right to Buy) | $6.19 | Mar 3, 2015 | X | 30,179 | A | May 28, 2013 | May 28, 2017 | Common Stock | 30,179 | 0 | D |
| NonQualified Stock Option (Right to Buy) | $6.22 | Mar 3, 2015 | X | 52,500 | A | May 21, 2012 | May 21, 2016 | Common Stock | 52,500 | 0 | D |
Explanation of responses
- F1Mr Midyett surrendered to the Issuer the right to receive an aggregate of 19,610 shares of Common Stock. Mr Midyett did not sell any shares of Common Stock in connection with the foregoing exercise.
- F2Mr Midyett surrendered to the Issuer the right to receive an aggregate of 34,410 shares of Common Stock. Mr Midyett did not sell any shares of Common Stock in connection with the foregoing exercise.
- F3Mr Midyett surrendered to the Issuer the right to receive an aggregate of 16,164 shares of Common Stock. Mr Midyett did not sell any shares of Common Stock in connection with the foregoing exercise.